Ravindre Panchia to Tenofovir
This is a "connection" page, showing publications Ravindre Panchia has written about Tenofovir.
Connection Strength
0,672
-
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. J Int AIDS Soc. 2024 Dec; 27(12):e26389.
Score: 0,219
-
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):376-383.
Score: 0,178
-
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2018 11; 18(11):1241-1250.
Score: 0,144
-
HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial. PLoS One. 2017; 12(6):e0178594.
Score: 0,131